Neuronal nucleus and cytoplasm volume deficit in children with autism and volume increase in adolescents and adults

Acta Neuropathologica Communications

Volumn 3, Issue 1, 2015, Pages

  Wegiel, Jerzy ^a   Flory, Michael ^a   Kuchna, Izabela ^a   Nowicki, Krzysztof ^a   Ma, Shuang Yong ^a   Imaki, Humi ^a   Wegiel, Jarek ^a   Frackowiak, Janusz ^a   Kolecka, Bozena Mazur ^a   Wierzba Bobrowicz, Teresa ^b   London, Eric ^a   Wisniewski, Thomas ^c   Hof, Patrick R ^d   Brown, W Ted ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Cytoplasm volume; Neuron development; Neuropathology; Nucleus volume

Indexed keywords

ADOLESCENT; ADULT; AGE; AUTISM; BRAIN; CASE CONTROL STUDY; CELL NUCLEUS; CHILD; CYTOPLASM; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; MIDDLE AGED; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AUTISTIC DISORDER; BRAIN; CASE-CONTROL STUDIES; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CYTOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURONS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84933500016     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/s40478-015-0183-5     Document Type: Article

References (103)

1. DiCiccio-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, et al. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006;26:6897-906.
2. OzonoffS, Heung K, Byrd R, Hansen R, Hertz-Picciotto I. The onset of autism: Patterns of symptom emergence in the first years of life. Autism Res. 2008;1:320-8.
3. Zwaigenbaum L, Thurm A, Stone W, Baranek G, Bryson S, Iverson J, et al. Studying the emergence of autism spectrum disorders in high-risk infants: methodological and practical issues. J Autism Dev Disord. 2007;37:466-80.
4. Zwaigenbaum L, Bryson S, Rogers T, Roberts W, Brian J, Szatmari P. Behavioral manifestations of autism in the first year of life. Int J Dev Neurosci. 2005;23:143-52.
5. Landa R, Garrett-Mayer E. Development in infants with autism spectrum disorders: a prospective study. J Child Psychol Psychol. 2006;47:629-38.
6. Lord C, Risi S, Lambrecht L, Cook Jr EH, Leventhal BL, DiLavore PC, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000;30:205-23.
7. Smith LE, Maenner MJ, Seltzer MM. Developmental trajectories in adolescents and adults with autism: the case of daily living skills. J Am Acad Child Adolesc Psychiatry. 2012;51:622-31.
8. Courchesne E, Carper R, AkshoomoffN. Evidence of brain overgrowth in the first year of life in autism. JAMA. 2003;290:337-44.
9. Courchesne E, Redcay E, Kennedy DP. The autistic brain: birth through adulthood. Curr Opin Neurol. 2004;17:489-96.
10. Dementieva YA, Vance DD, Donnelly SL, Elston LA, Wolpert CM, Ravan SA, et al. Accelerated head growth in early development of individuals with autism. Pediatr Neurol. 2005;32:102-8.
11. Redcay E, Courchesne E. When is the brain enlarged in autism? A metaanalysis of all brain size reports. Biol Psychiatry. 2005;58:1-9.
12. Kosaka H, Omori M, Munesue T, Ishitobi M, Matsumara Y, Takahashi T, et al. Smaller insula and inferior frontal volumes in young adults with pervasive developmental disorders. Neuroimage. 2010;50:1357-63.
13. Stefanatos GA. Regression in autistic spectrum disorders. Neuropsychiatr Rev. 2008;18:305-19.
14. OzonoffS, Iosif A, Baguio F, Cook IC, Hill MM, Hutman T, et al. A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:258-68.
15. Goldberg WA, Osann K, Filipek PA, Laulhere T, Jarvis K, Modahl C, et al. Language and other regression: assessment and timing. J Autism Dev Disord. 2003;33:607-16.
16. Malhi P, Singhi P. Regression in children with autism spectrum disorders. Indian J Pediatr. 2012;27:975-81.
17. Hansen RL, OzonoffS, Krakowiak P, Angkustsiri K, Jones C, Deprey LJ, et al. Regression in autism: Prevalence and associated factors in the CHARGE study. Pediatrics. 2008;8:25-31.
18. Dawson G, Munson J, Webb SJ, Nalty T, Abbott R, Toth K. Rate of head growth decelerates and symptoms worsen in the second year of life in autism. Biol Psychiatry. 2007;61:458-64.
19. Wegiel J, Kuchna I, Nowicki K, Imaki H, Wegiel J, Marchi E, et al. The neuropathology of autism: Defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 2010;119:755-70.
20. Wegiel J, Schanen NC, Cook EH, Sigman M, Brown WT, Kuchna I, et al. Differences between the pattern of developmental abnormalities in autism associated with duplications 15q11.2-q13 and idiopathic autism. J Neuropathol Exp Neurol. 2012;71:382-97.
21. Tuchman R, Rapin I. Epilepsy in autism. Lancet Neurol. 2002;1:352-8.
22. Volkmar FR, Nelson DS. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry. 1990;29:127-9.
23. Woolfenden S, Sarkozy V, Ridley G, Coory M, Williams K. A systemic review of two outcomes in autism spectrum disorder: epilepsy and mortality. Dev Med Child Neurol. 2012;54:306-12.
24. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform encephalogram correlates. Pediatrics. 1997;99:560-6.
25. Holmes GL. Effects of early seizures on later behavior and epileptogenicity. Ment Retard Dev Disabil Res Rev. 2004;10:101-5.
26. Tuchman R, Hirtz D, Mamounas LA. NINDS epilepsy and autism spectrum disorders workshop report. Neurology. 2013;81:1630-6.
27. Wegiel J, Flory M, Kuchna I, Nowicki K, Ma SY, Imaki H, et al. Brain-regionspecific alterations of the trajectories of neuronal volume growth throughout the lifespan in autism. Acta Neuropathol Comm. 2014;2:28.
28. Edens LJ, White KH, Jevtic P, Li X, Levy DL. Nuclear size regulation: from single cells to development and disease. Trends Cell Biol. 2013;23:151-9.
29. Levy DL, Heald R. Mechanisms of intracellular scaling. Annu Rev Cell Dev Biol. 2012;28:113-35.
30. Centers for Disease Control and Prevention. Prevalence of Autism Spectrum Disorder Among Children Aged 8 years. Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2010. MMWR 2014, 63:1-21.
31. Casanova MF, El-Baz AS, Kamat SS, Dombroski BA, Khalifa F, Elnakib A, et al. Focal cortical dysplasias in autism spectrum disorders. Acta Neuropathol Comm. 2013;1:67.
32. Jacot-Descombes S, Uppal N, Wicinski B, Santos M, Schmeidler J, Giannakopoulos P, et al. Decreased pyramidal neuron size in Brodmann areas 44 and 45 in patients with autism. Acta Neuropathol. 2012;124:67-79.
33. Santos M, Uppal N, Butti C, Wicinski B, Schmeidler J, Giannakopoulos P, et al. Von economo neurons in autism: a stereologic study of the frontoinsular cortex in children. Brain Res. 2011;1380:206-17.
34. van Kooten IAJ, Palmen SJMC, von Cappeln P, Steinbusch HWM, Korr H, Heinsen H, et al. Neurons in the fusiform gyrus are fewer and smaller in autism. Brain. 2008;131:987-99.
35. Wegiel J, Flory M, Kuchna I, Nowicki K, Ma SY, Imaki H, et al. Stereological study of the neuronal number and volume of 38 brain subdivisions of autistic subjects reveals significant alterations restricted to the striatum, amygdale and cerebellum. Acta Neuropathol Comm. 2014;2:141.
36. Heinsen H, Arzberger T, Schmitz C. Celloidin mounting (embedding without infiltration)-a new, simple and reliable method for producing serial sections of high thickness through complete human brains and its application to stereological and immunohistochemical investigations. J Chem Neuroanat. 2000;20:49-59.
37. Gundersen HJ. The nucleator. J Microsc. 1988;151:3-21.
38. Gundersen HJG, Jensen EBV. The efficiency of systematic sampling - reconsidered. J Micr. 1999;193:199-211.
39. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc N57. 1995;1:289-300.
40. StataCorp. Stata: Release 11. Statistical Software. College Station, TX: StataCorp LP; 2009.
41. StataCorp. Stata: Release 12. Statistical Software. College Station, TX: StataCorp LP; 2011.
42. Casanova MF, van Kooten IAJ, Switala AE, van Engeland H, Heinsen H, Steinbusch HW, et al. Minicolumnar abnormalities in autism. Acta Neuropathol. 2006;112:287-303.
43. Uppal N, Wicinski B, Buxbaum JD, Heinsen H, Schmitz C, Hof PR. Neuropathology of the anterior midcingulate cortex in young children with autism. J Neuropathol Exp Neurol. 2014;73:891-902.
44. Simms ML, Kemper TL, Timbie CM, Bauman ML, Blatt GJ. The anterior cingulate cortex in autism: Heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups. Acta Neuropathol. 2009;118:673-84.
45. Fatemi SH, Halt AR, Realmuto G, Earle J, Kist DA, Thuras P, et al. Purkinje cell size is reduced in cerebellum of patients with autism. Cell Mol Neurobiol. 2002;22:171-5.
46. Kulesza Jr RJ, Lukose R, Stevens LV. Malformation of the human superior olive in autistic spectrum disorders. Brain Res. 2011;1367:360-71.
47. Bauman ML, Kemper TL. Histoanatomic observations of the brain in early infantile autism. Neurology. 1985;35:866-7.
48. Raymond G, Bauman ML, Kemper TL. The hippocampus in autism: Golgi analysis. Ann Neurol. 1996;91:117-9.
49. Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropath Exp Neurol. 1998;57:645-52.
50. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism. In: Bauman ML, Kemper TL, editors. The Neurobiology of Autism. Baltimore: John Hopkins Univ Press; 1994. p. 119-45.
51. Baghdadli A, Pascal C, Grisi S, Aussilloux C. Risk factors for self-injurious behaviours among 222 young children with autistic disorders. J Intell Disabil Res. 2003;47:622-7.
52. SimonoffE, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry. 2008;47:921-9.
53. Uppal N, Gianatiempo I, Wicinski B, Schmeidler J, Heinsen H, Schmitz C, et al. Neuropathology of the posterior occipitotemporal gyrus in children with autism. Molec Autism. 2014;5:17.
54. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, et al. Neuron number and size in prefrontal cortex of children with autism. JAMA. 2011;306:2001-10.
55. Mazur-Kolecka B, Cohen IL, Jenkins EC, Kaczmarski W, Flory M, Frackowiak J. Altered development of neuronal progenitor cells after stimulation with autistic blood. Brain Res. 2007;1168:11-20.
56. Schumann CM, Amaral DG. Stereological analysis of amygdala neuron number in autism. J Neurosci. 2006;26:7674-9.
57. Nagarajan RP, Hogart AR, Gwye Y, Martin MR, LaSalle JM. Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics. 2006;1:e1-11.
58. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185-8.
59. Christodoulou J, Grimm A, Maher T, Bennetts B. RettBASE: the IRSA MECP2 variation database-a new mutation database in evolution. Hum Mutat. 2003;21:466-72.
60. Shahbazian MD, Antalaffy B, Armstrong DL, Zoghbi HY. Insight into Rett syndrome: MeCP2 levels display tissue-and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet. 2002;11:115-24.
61. Jellinger K, Armstrong D, Zoghbi HY, Percy AK. Neuropathology of Rett syndrome. Acta Neuropathol. 1988;76:142-58.
62. Reiss AL, Faruque F, Naudy S, Abrams M, Beaty T, Bryan RN, et al. Neuroanatomy of Rett syndrome: A volumetric imaging study. Ann Neurol. 1993;34:227-43.
63. Kaufmann WE, Moser HW. Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex. 2000;10:981-91.
64. Casanova MF, Buxhoeveden D, Switala A, Roy E. Rett syndrome as a minicolumnopathy. Clin Neuropathol. 2003;22:163-8.
65. Armstrong DD. Neuropathology of Rett syndrome. J Child Neurol. 2005;20:747-53.
66. Kishi N, Macklis JD. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci. 2004;27:306-21.
67. Fukuda T, Itoh M, Ichikawa T, Washiyama K, Goto Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol. 2005;64:537-44.
68. Gonzales ML, LaSalle JM. The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep. 2010;12:127-34.
69. Nan X, Meehan RR, Bird A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res. 1993;21:4886-92.
70. Singleton MK, Gonzales ML, Leung KN, Yasui DH, Schroeder DI, Dunaway K, et al. MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation. Neurobiol Dis. 2011;43:190-200.
71. Yazdani M, Deogracias R, Guy J, Poot RA, Bird A, Barde YA. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells. 2012;30:2128-39.
72. Giacometti E, Luikenhuis S, Beard C, Jaenish R. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci U S A. 2007;104:1931-6.
73. Fillano JJ, Goldenthal MJ, Rhodes CH, Marin-Garcia J. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J Child Neurol. 2002;17:435-9.
74. Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D, et al. Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation. J Child Neurol. 2000;15:357-61.
75. Gu F, Chauhan V, Kaur K, Brown WT, LaFauci G, Wegiel J, et al. Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatry. 2013;3:e299. doi:10.1038/tp.2013.68.
76. Chugani DC, Sundram BS, Behen M, Lee ML, Moore GJ. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry. 1999;23:635-41.
77. Filipek PA, Juranek J, Smith M, Mays LZ, Ramos ER, Bocian M, et al. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann Neurol. 2003;53:801-4.
78. Oliveira G, Diogo L, Grazina M, Garcia P, Ataide A, Marques C, et al. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol. 2005;47:185-9.
79. Giulivi C, Zhang Y-F, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I, et al. Mitochondrial dysfunction in autism. JAMA. 2010;304:2389-96.
80. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, et al. Brain regionspecific deficit in mitochondrial electron transport chain complex in children with autism. J Neurochem. 2011;117:209-20.
81. Scholes TA, Hinkle PC. Energetics of ATP-driven reverse electron transfer from cytochrome c to fumarate and from succinate to NAD in submitochondrial particles. Biochemistry. 1984;23:3341-5.
82. Bertram R, Gram PM, Luciani DS, Sherman A. A simplified model for mitochondrial ATP production. J Theor Biol. 2006;243:575-86.
83. Tang G, Rios PG, Kuo S-H, Akman HO, Rosoklija G, Tanji K, et al. Mitochondrial abnormalities in temporal lobe of autistic brain. Neurobiol Dis. 2013;54:349-61.
84. Han X-J, Tomizawa K, Fujimura A, Ohmori I, Nishiki T, Matsushita M, et al. Regulation of mitochondrial dynamics and neurodegenerative diseases. Acta Med Okayama. 2011;65:1-10.
85. Kraft C, Peter M, Hofmann K. Selective autophagy: Ubiquitin-mediated recognition and beyond. Nat Cell Biol. 2010;12:836-41.
86. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459:569-73.
87. Scheuerle A, Wilson K. PARK2 copy number aberrations in two children presenting with autism spectrum disorder: further support of an association and possible evidence for a new microdeletion/microduplication syndrome. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:413-20.
88. Sokol DK, Maloney B, Long JM, Ray B, Lahiri DK. Autism, Alzheimer disease, and fragile X. APP, FMRP, and mGluR5 are molecular links. Neurology. 2011;76:1344-52.
89. Ray B, Long JM, Sokol DK, Lahiri DK. Increased secreted amyloid precursor protein-a (sAPPa) in severe autism: proposal of a specific, anabolic pathway and putative biomarker. PLoS One. 2011;6(e20405):1-10.
90. Westmark CJ. What's happening at synapses? The role of amyloid ß-protein precursor and ß-amyloid in neurological disorders. Mol Psychiatry. 2013;18:425-34.
91. Sajdel-Sulkowska EM, Xu M, Koibuchi N. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum. 2009;8:366-72.
92. Frackowiak J, Mazur-Kolecka B, Schanen NC, Brown WT, Wegiel J. The link between intraneuronal N-truncated amyloid b-peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism. Acta Neuropathol Comm. 2013;1:61.
93. Lopez-Hurtado E, Prieto JJ. A microscopic study of language-related cortex in autism. Am J Biochem Biotech. 2008;4:130-45.
94. Hardy J. The amyloid hypothesis of Alzheimer's disease: a critical reappraisal. J Neurochem. 2009;110:1129-34.
95. Sokol DK, Chen D, Farlow MR, Dunn DW, Maloney B, Zimmer JA, et al. High levels of Alzheimer-beta amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J Child Neurol. 2006;21:444-9.
96. Westmark CJ, Malter JS. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS One. 2007;5:e52.
97. Westmark CJ, Westmark PR, O'Riordan KJ, Ray BC, Hervey CM, Salamat MS, et al. Reversal of fragile X phenotypes by manipulation of AßPP/Aß levels in Fmr1KO mice. PLoS One. 2011;6(10):e26549.
98. Bailey AR, Giunta BN, Obregon D, Nikolic WV, Tian J, Sanberg CD, et al. Peripheral biomarkers in autism: secreted amyloid precursor protein-a as a probable key player in early diagnosis. Int J Clin Exp Med. 2008;1:338-44.
99. Wegiel J, Kuchna I, Nowicki K, Frackowiak J, Mazur-Kolecka B, Imaki H, et al. Intraneuronal Aß immunoreactivity is not a predictor of brain amyloidosis-ß or neurofibrillary degeneration. Acta Neuropathol. 2007;113:389-402.
100. Wegiel J, Frackowiak J, Mazur-Kolecka B, Schanen NC, Cook EH, Sigman M, et al. Abnormal intracellular accumulation and extracellular Aß deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders. PLoS One. 2012;7(5):e35414.
101. Wegiel J, Kuchna I, Nowicki K, Imaki H, Wegiel J, Ma SY, et al. Contribution of olivo-floccular circuitry developmental defects to atypical gaze in autism. Brain Res. 2013;1512:106-22.
102. Chauhan A, Chauhan V, Brown WT, Cohen I. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferring-the antioxidant proteins. Life Sci. 2004;75:2539-49.
103. Chauhan V, Chauhan A. Abnormalities in membrane lipids, membraneassociated proteins, and signal transduction in autism. In: Chauhan A, Chauhan V, Brown WT, editors. Autism. Oxidative Stress, Inflammation and Immune Abnormalities, Taylor and Francis Group. Boca Raton, FL: CRC Press; 2010. p. 177-206.